1209069004: Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)

• SNOMED CT Concept\produit pharmaceutique ou biologique\Medicinal product (product)\...
• \Medicinal product categorized by disposition (product)\inhibiteur enzymatique\Product containing transferase inhibitor (product)\Product containing phosphotransferase inhibitor (product)\Product containing protein kinase inhibitor (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Trastuzumab emtansine-containing product\Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Medicinal product categorized by disposition (product)\inhibiteur enzymatique\Product containing transferase inhibitor (product)\Product containing phosphotransferase inhibitor (product)\Product containing protein kinase inhibitor (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Trastuzumab emtansine-containing product\Trastuzumab emtansine only product\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Trastuzumab emtansine-containing product\Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Trastuzumab emtansine-containing product\Trastuzumab emtansine only product\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing polypeptide (product)\Product containing protein (product)\Product containing antibody (product)\Product containing monoclonal antibody (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Trastuzumab emtansine-containing product\...
• \Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Trastuzumab emtansine only product\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Medicinal product categorised by therapeutic role\Medicinal product acting as antineoplastic agent (product)\...
• \Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Trastuzumab emtansine-containing product\...
• \Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Trastuzumab emtansine only product\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Trastuzumab emtansine-containing product\...
• \Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Trastuzumab emtansine only product\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Product manufactured as parenteral dose form (product)\Trastuzumab emtansine-containing product in parenteral dose form\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-May 2022. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
5014317010	Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5014318017	Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

Reference Sets

Canada English language reference set (foundation metadata concept)

Description inactivation indicator reference set

GB English

US English

Back to Start